DS
ADPT icon

David Shaw’s Adaptive Biotechnologies ADPT Stock Holding History

David Shaw’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.2M Buy
4,625,859
+2,660,249
+135% +$40.8M 0.05% 455
2026
Q1 		$27.3M Buy
1,965,610
+62,925
+3% +$1M 0.02% 962
2025
Q4 		$30.9M Buy
1,902,685
+1,164,509
+158% +$19M 0.02% 976
2025
Q3 		$11M Buy
738,176
+129,896
+21% +$1.58M 0.01% 1599
2025
Q2 		$7.09M Buy
+608,280
New +$5.53M 0.01% 1756
2024
Q1 		– Sell
-41,743
Closed -$205K – 4299
2023
Q4 		$205K Sell
41,743
-89,526
-68% -$408K ﹤0.01% 3876
2023
Q3 		$715K Buy
131,269
+43,321
+49% +$286K ﹤0.01% 3263
2023
Q2 		$590K Sell
87,948
-139,781
-61% -$1.04M ﹤0.01% 3355
2023
Q1 		$2.01M Buy
227,729
+111,547
+96% +$983K ﹤0.01% 2695
2022
Q4 		$888K Buy
116,182
+57,498
+98% +$447K ﹤0.01% 3530
2022
Q3 		$418K Sell
58,684
-97,500
-62% -$918K ﹤0.01% 4136
2022
Q2 		$1.26M Buy
156,184
+23,981
+18% +$211K ﹤0.01% 3466
2022
Q1 		$1.83M Buy
+132,203
New +$2.08M ﹤0.01% 3386
2020
Q3 		– Sell
-19,068
Closed -$923K – 3783
2020
Q2 		$923K Buy
+19,068
New +$695K ﹤0.01% 2994
2020
Q1 		– Sell
-27,456
Closed -$821K – 3886
2019
Q4 		$821K Buy
+27,456
New +$788K ﹤0.01% 3116

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

David Shaw's ADPT Position: Q2 2026 in Review

David Shaw increased its Adaptive Biotechnologies (ADPT) stake by 135% in Q2 2026, buying an estimated $40.8M and bringing the position to 4,625,859 shares worth $99.2M. The position accounts for 0.05% of the portfolio, ranked #455.

David Shaw first reported a position in ADPT in Q4 2019 and has held it in 15 quarters since. 298 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • David Shaw held 4,625,859 shares of Adaptive Biotechnologies worth $99.2M as of Q2 2026.
  • David Shaw bought 2,660,249 Adaptive Biotechnologies shares in Q2 2026, an estimated $40.8M.
  • Adaptive Biotechnologies made up 0.05% of David Shaw's portfolio in Q2 2026, its #455 holding.
  • David Shaw first reported a position in Adaptive Biotechnologies in Q4 2019 and has held it in 15 quarters since.
  • 298 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.